Efficacy of Vibration Therapy on Restless Legs Syndrome and Sleep Disturbances Among Patients Undergoing Hemodialysis

Launched by AMJED ABDULABBAS SHRAIDA · Mar 15, 2025

Keywords

ClinConnect Summary

This clinical trial is studying whether vibration therapy can help reduce symptoms of Restless Legs Syndrome (RLS) and improve sleep for patients who are undergoing hemodialysis, which is a treatment for kidney failure. The main goal is to find out if patients who receive vibration therapy will experience less RLS and better sleep compared to those who do not receive this therapy. Participants in the study will receive vibration therapy on their calf muscles for 10 minutes, two times a week, during their hemodialysis sessions for one month.

To be eligible for this trial, patients must have been on hemodialysis for at least three months and attend two or more sessions each week. They should also be able to communicate and agree to participate voluntarily. However, patients who are in emergency situations, currently taking medication for RLS, using vibration therapy at home, or have certain health issues like severe heart problems, will not be included in the study. This trial will help us understand if vibration therapy can be a helpful treatment option for those dealing with RLS and sleep disturbances during hemodialysis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients passing at least three months after first their hemodialysis
• • Patients who are receiving two or more HD sessions a week, to facilitate patient follow-up.
• • Patients who are willing to participate, because the patients' participation is voluntary.
• • Patients who are alert and able to communicate verbally, to make the program applicable and facilitate the data collection.
• Exclusion Criteria:
• • Emergency hemodialysis patients, to avoid mal-efficient (apply the program in a harmless manner).
• • Intake of drugs for restless leg syndrome and sleep disturbances.
• • Using vibration and massage therapy at home
• • Recent history of deep vein thrombosis or other vascular complications.
• • Patients who are unable to communicate, because the patients' communication is an essential part of data collection.
• • Patients with severe cardiovascular disorders such as unstable angina, recent myocardial infarction or severe heart failure, because the application of the program may increase cardiovascular stress, which may pose a risk to these patients.